Effect of Nicotine Pouches on The Underlying Normal Electrocardiogram A Double-Blinded, Placebo-Controlled Cross-over Study Exploring the Dose-Response Effects of Nicotine Pouches on Heart Rate and the Electrocardiogram ACRONYM: The NICOTUNE Study
| Registry | NCT07057440, acronym NICOTUNE |
|---|---|
| Status | Completed |
| Phase | Not applicable |
| Study type | Interventional; randomized, crossover, masking: quadruple, prevention |
| Enrollment | 20 (Actual) |
| Sponsor | Ekim Seven (Other) |
| Conditions | Heart Rate, ECG, Vital Sign Monitoring, Symptoms |
| Interventions | High-dose Nicotine Pouch, Low Dose Nicotine Pouch, Placebo Pouch (Other) |
| Dates | start 2025-06-27, primary completion 2025-10-31, completion 2025-10-31, first posted 2025-07-09, last updated 2025-12-11 |
| Locations | 1 site in Denmark |
Related Papers Related Patents Related Grants Related Experts
All trials for Heart Rate All trials for ECG All trials of High-dose Nicotine Pouch All trials of Low Dose Nicotine Pouch
Nicotine pouches (NPs) are increasingly being used by children, adolescents, and adults, and are often presented as a less harmful alternative to, for example, smoking. The ability to use these products discreetly (unlike smoking) makes them an attractive option for individuals who wish to avoid the stigma that smokers may sometimes experience.
Nicotine is a well-known addictive substance that affects many organ systems, including the heart and circulatory system. The amount of nicotine in NPs varies greatly, but the pouches can contain large amounts of nicotine compared to the content of a single cigarette. While many studies have previously examined the effects of smoking and other nicotine products on the heart and circulatory system, specific data on the effects of NPs on these same systems are rather limited.
In light of the above, the investigators have planned a study to investigate whether NPs affect the circulatory system and heart rate, assessed through electrocardiography (ECG) and vital signs (i.e., pulse, blood pressure, respiratory rate, and more).
The investigators hypothesis is that the nicotine content in NPs leads to notable changes in the aforementioned measurements and could therefore potentially be associated with an increased health risk.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Placebo pouch arm | Placebo comparator | Other: Placebo Pouch | |
| Low-dosage nicotine pouch arm | Experimental | Other: Low Dose Nicotine Pouch | |
| High-dosage nicotine pouch arm | Experimental | Other: High-dose Nicotine Pouch |
Sex: All, ages: 18 Years to 70 Years, accepts healthy volunteers
Inclusion Criteria: * Adults aged 18-70 years. * Regular (defined as daily) or occasional (generally defined as nondaily) nicotine users (e.g., cigarettes, vaping, or nicotine pouches). * Willingness to abstain from nicotine, caffeine (including caffeine containing energy drinks), and alcohol for 6 hours prior to the session Exclusion Criteria: * History of cardiovascular conditions. * Medications affecting cardiac conduction or autonomic function (e.g., antiarrhythmic drugs). * Pregnancy or breastfeeding. * Current illness or infection. * History of substance abuse.
| Facility | City | Country | Status |
|---|---|---|---|
| Department of cardiology, Copenhagen University Hospital, Amager & Hvidovre | Hvidovre | Denmark |